These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 3001275)

  • 21. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.
    Mayeux PR; Morton HE; Gillard J; Lord A; Morinelli TA; Boehm A; Mais DE; Halushka PV
    Biochem Biophys Res Commun; 1988 Dec; 157(2):733-9. PubMed ID: 2974286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
    Narumiya S; Okuma M; Ushikubi F
    Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparations.
    Bowling N; Dubé GP; Kurtz WL; Brune KA; Saussy DL; Dorn GW; Mais DE
    J Mol Cell Cardiol; 1994 Jul; 26(7):915-23. PubMed ID: 7966360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
    Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
    Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets.
    Burch RM; Mais DE; Saussy DL; Halushka PV
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7434-8. PubMed ID: 2997791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548).
    Kattelman EJ; Venton DL; Le Breton GC
    Thromb Res; 1986 Feb; 41(4):471-81. PubMed ID: 3008368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets.
    Liel N; Mais DE; Halushka PV
    Prostaglandins; 1987 Jun; 33(6):789-97. PubMed ID: 2959986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction.
    Dorn GW; Liel N; Trask JL; Mais DE; Assey ME; Halushka PV
    Circulation; 1990 Jan; 81(1):212-8. PubMed ID: 2137044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets.
    Fonlupt P; Croset M; Lagarde M
    Thromb Res; 1991 Jul; 63(2):239-48. PubMed ID: 1837628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand.
    Zehender H; Witte EC; Wolff HP; Patscheke H
    Biochem Pharmacol; 1988 Feb; 37(3):491-5. PubMed ID: 2962585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photoaffinity labelling of a thromboxane A2/prostaglandin H2 antagonist binding site in human platelets.
    Mais DE; Burch RM; Oatis JE; Knapp DR; Halushka PV
    Biochem Biophys Res Commun; 1986 Oct; 140(1):128-33. PubMed ID: 2946292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
    Turini ME; Holub BJ
    Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
    Masuda A; Mais DE; Oatis JE; Halushka PV
    Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145.
    Hanasaki K; Nagasaki T; Arita H
    Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of an [125I] labelled thromboxane A2/prostaglandin H2 receptor agonist to baboon platelets.
    Dorn GW; De Jesus A
    Prostaglandins; 1989 Dec; 38(6):645-53. PubMed ID: 2534431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The binding of [3H]9,11-dideoxy,9 alpha-11 alpha-methanoepoxy prostaglandin F2 alpha (U 46619) to washed human platelets.
    Jaschonek K; Faul C; Weisenberger H; Schmidt H; Renn W
    Prog Clin Biol Res; 1989; 301():327-33. PubMed ID: 2529551
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand.
    Halushka PV; MacDermot J; Knapp DR; Eller T; Saussy DL; Mais D; Blair IA; Dollery CT
    Biochem Pharmacol; 1985 Apr; 34(8):1165-70. PubMed ID: 2986639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.